Longduoduo Co Ltd. Stock Analysis LDDD
Longduoduo Co. Ltd. provides preventive healthcare solutions and services. The company is headquartered in Hohhot, Neimenggu and currently employs 52 full-time employees. The company went IPO on 2022-08-17. The firm provides solution for chronic disease problems through non-drug treatments and prevents cardiovascular and cerebrovascular diseases in advance. The firm offers health consultation and advice to customers and sells treatment services to customers, provided by Longduoduo to customers in local cooperative medical institutions. The firm's treatment projects mainly include ozone autologous blood transfusion (immunotherapy), Xingnao Tongluo therapy, double blood purification, platelet-rich plasma (PRP) injection therapy and others. The firm's products and services are mainly used for the prevention of myocardial infarction, cerebral infarction, hemiplegia, cardiovascular and cerebrovascular diseases.
Read More Longduoduo Co Ltd (LDDD) Chart
Key Statistics of Longduoduo Co Ltd (LDDD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.51Volume
-P/E Ratio (TTM)
33.2552 Week Range
Market Cap
15.31MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Longduoduo Co Ltd (LDDD)
FAQ's for Longduoduo Co Ltd (LDDD)
- According to Musaffa’s Shariah screening methodology, Longduoduo Co Ltd (LDDD) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.